You just read:

Brain Cancer Patients Display Decreasing Tumor Biomarkers After Treatment with Novel Immunotherapy in AIVITA Biomedical's Phase 2 Clinical Trial

News provided by

AIVITA Biomedical

Aug 14, 2019, 07:00 ET